Custom Antibody Market Report Future Development, Top Key Players, Share, Size and Forecast to 2028
In December 2022, Merck KGaA collaborated with Kelun-Biotech to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer.
View full press release